Back to Archive

SensUs 2026

Parkinson's monitoring

Biomarker: Levodopa

The Theme

SensUs 2026 aims to track levodopa fluctuations through continuous monitoring. This will help personalize treatment for Parkinson's disease patients and make a step towards closed-loop levodopa therapy!

Results

Innovation Award

Translation Potential Award

Analytical Performance Award

Public Inspiration Award

The Teams

A-levo

A-levo

McGill University

TRD
Aixsense

Aixsense

RWTH Aachen

TRD
BarceL-DOPA

BarceL-DOPA

Universitat Politècnica de Catalunya

TRD
BiosensUM

BiosensUM

Université de Montréal & Polytechnique Montréal

TRD
Biosense EPFL

Biosense EPFL

EPFL

TRD
Biosensing Team Twente

Biosensing Team Twente

University of Twente

TRD
DeTectUs

DeTectUs

Technical University of Denmark

TRD
G-Pulse

G-Pulse

Istanbul Technical University

TRD
GlaSense

GlaSense

University of Glasgow

TRD
MakeSense

MakeSense

ShanghaiTech University

TRD
Munich Bioneers

Munich Bioneers

Technical University of Munich

TRD
ParisBiotek

ParisBiotek

Institut Polytechnique de Paris

TRD
SensETH

SensETH

ETH Zürich

TRD
SensTech

SensTech

Cornell University

TRD
SenseNC

SenseNC

North Carolina State University

TRD
TUcanSense

TUcanSense

TU Darmstadt

TRD
TruSense

TruSense

Zhejiang University

TRD
UCTeam

UCTeam

University of Chemistry and Technology, Prague

TRD